Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04077177 · ClinicalTrials.gov registry record · NA
Decreasing Body Dissatisfaction in Male College Athletes: A Randomized Controlled Trial of the Male Athlete Body Project
A NA study, sponsored by Illinois Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT04077177: Completed NA study, sponsored by Illinois Institute of Technology.
NCT04077177 is a NA study that has completed, run by Illinois Institute of Technology. The registered enrollment target is 83 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04077177, a NA study, has completed, sponsored by Illinois Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
Body Dissatisfaction (BD) is associated with marked distress and often precipitates disordered eating symptomology (Milligan \& Pritchard, 2006). BD in male athletes is an important area to explore, as research in this field often focuses on eating disorders in female athletes (e.g., Becker et al., 2012; Varnes et al., 2013). The current body of literature regarding male college athletes suggests that they experience pressures associated with both societal muscular ideals and sport performance (Galli et al., 2015). While there is a clear association between drive for muscularity and BD in collegiate male athletes (Galli et al., 2015), no study to date has conducted research aimed to attenuate the effect of BD in this population. The current study seeks to investigate a BD intervention for male college athletes. Participants will be randomized to an adapted version of the standardized Female Athlete Body Project (i.e., the Male Athlete Body Project) or an assessment only control condition. All participants will complete baseline and post-treatment measures of BD, negative affect, internalization of an athletic ideal, drive for muscularity, sport confidence, eating pathology, and unhealthy weight-control behaviors. Study aims are to determine if the Male Athlete Body Project intervention group reduces BD and related factors post-treatment, and to investigate whether these differences are maintained at 1-month follow up. Results will inform mental health and sport clinicians, coaches, and other personnel involved in an athlete's care about successful strategies for decreasing BD.
Primary Outcome
This measure assesses body dissatisfaction and appearance concerns over 34 items. The total score will not be interpreted; instead, subscale scores will be reported and interpreted. The subscales are: Appearance Evaluation, Appearance Orientation, Overweight Preoccupation, Self-Classified Weight, and the Body Areas Satisfaction Scale. For the Appearance Evaluation subscale, higher scores indicate a better outcome. Scores range from 7-35. For Appearance Orientation, higher scores indicate a worse
Interventions
- BEHAVIORAL Male Athlete Body Project
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2019-02-15 |
| Est. Completion | 2020-03-20 |
| Phase | NA |
What the finished NCT04077177 record still lists
NCT04077177 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Male Athlete Body Project is the first listed.
NCT04077177 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04077177 about?
NCT04077177 is a clinical study titled "Decreasing Body Dissatisfaction in Male College Athletes: A Randomized Controlled Trial of the Male Athlete Body Project". Body Dissatisfaction (BD) is associated with marked distress and often precipitates disordered eating symptomology (Milligan \& Pritchard, 2006). BD in male athletes is an important area to explore, as research in this field often focuses on eating disorders in female athletes (e.g., Becker et al., ...
What is the current status of trial NCT04077177?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2019-02-15. Estimated completion is 2020-03-20.
What interventions are being tested in trial NCT04077177?
The interventions under investigation include: Male Athlete Body Project (BEHAVIORAL).
Who is sponsoring clinical trial NCT04077177?
This trial is sponsored by Illinois Institute of Technology, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04077177's enrollment target sits among peer trials
83 990th of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI